Elsevier

Biomaterials

Multiple-aqueduct scaffolds to promote spinal cord axon regeneration

Abstract

Every bit molecular, cellular, and tissue-level treatments for spinal cord injury are discovered, it is probable that combinations of such treatments will be necessary to elicit functional recovery in animal models or patients. We describe multiple-channel, biodegradable scaffolds that serve every bit the footing for a model to investigate simultaneously the effects on axon regeneration of scaffold architecture, transplanted cells, and locally delivered molecular agents. Poly(lactic-co-glycolic acid) (PLGA) with copolymer ratio 85:fifteen was used for these initial experiments. Injection molding with rapid solvent evaporation resulted in scaffolds with a plurality of distinct channels running parallel along the length of the scaffolds. The feasibility of creating scaffolds with various channel sizes and geometries was demonstrated. Walls separating open channels were found to possess void fractions equally high as 89%, with attainable void fractions as high as 90% through connections 220   μm or larger. Scaffolds degraded in vitro over a period of 30 weeks, over which time-sustained commitment of a surrogate drug was observed for 12 weeks. Primary neonatal Schwann cells were distributed in the channels of the scaffold and remained viable in tissue culture for at least 48   h. Schwann-prison cell containing scaffolds implanted into transected adult rat spinal cords contained regenerating axons at i month post-performance. Axon regeneration was demonstrated by 3-dimensional reconstruction of series histological sections.

Introduction

Advances in neuroscience over the past 2 decades begin to offer hope for spinal cord injury (SCI) victims. Since the demonstration in 1980 that central nervous system (CNS) axons have the chapters to regenerate inside peripheral nervous system (PNS) grafts [one], much has been accomplished toward understanding factors that contribute to a physiologically permissive environment. Mechanisms of injury, of regeneration, and of inhibition to regeneration are beingness delineated, and several promising handling strategies have arisen. Transplantation of a multifariousness of cell types, including Schwann cells [ii], [iii], olfactory ensheathing glial cells [iv], [5], or neural stem cells [vi], [seven], has resulted in axon regeneration and limited functional improvement after spinal cord injury in rats. Molecular therapies that work to promote regeneration, such as administration of neurotrophins [viii], [9], [ten], and those that target deleterious inhibition of regeneration, such as chondroitinase ABC [11], [12], [xiii], [fourteen], [xv], accept too yielded favorable results. Synthetic biomaterials accept been investigated for their power to reconstruct spinal cord tissue architecture, to provide guidance for regenerating axons, and to forbid the infiltration of scar tissue [sixteen], [17], [eighteen], [19]. A comprehensive review of neural regeneration strategies was recently provided past Schmidt and Baier Leach [xx].

Despite recent advances, the express demonstration of functional improvement in animal models has prevented advancement of any regenerative therapy to clinical use. This may be due in large office to the multifaceted nature of spinal string injuries, which presents a major challenge to therapeutic evolution. Primary mechanical trauma to the string induces secondary injury consisting of a complex cascade of molecular events that lead to the loss of myelin and the germination of a glial scar [21], [22]. Therefore, in order for feasible handling strategies to be realized clinically, information technology is likely that combinations of electric current therapeutic approaches must be used. Indeed, combinatorial approaches accept already shown promise in animal models. For example, assistants of neurotrophins enhanced axon growth into Schwann-jail cell seeded guidance channels and increased integration into the graft–host interface [23]. Synergistic effects on CNS axon regeneration have been demonstrated when strategies promoting regeneration and antagonizing inhibition were used simultaneously [24], [25].

An elegant solution may prevarication in the design of a bio-bogus graft that targets injury mechanisms at the molecular, cellular, and tissue levels. Biodegradable polymers tin can simultaneously provide a tissue scaffold, a cell delivery vehicle, and a reservoir for sustained drug delivery [16]. This integrative approach suggests a possible treatment strategy and may serve every bit an in vivo model for studying optimization of various combinations of treatments. We describe techniques for producing biodegradable polymer scaffolds with parallel-channel architecture that can exist systematically modified. They may be seeded with multiple cell types arranged spatially in anatomically relevant locations and may serve as a vehicle for sustained drug commitment. We quantitatively depict the scaffolds' architecture, their in vitro deposition profile, their drug delivery characteristics, their biocompatibility with Schwann cells in culture, and their promotion of in vivo axon regeneration.

Section snippets

Scaffold fabrication

Biodegradable scaffolds with controlled, parallel-channel architecture were fabricated past an injection molding, solvent evaporation technique. Cylindrical, Teflon molds, with diameter 3.0   mm were fitted with Delrin spacers containing an assortment of vii, uniformly spaced, 508- or 660-μm stainless-steel wires (Malin, Cleveland, OH), as shown in Fig. 1A. The wire arrays were spray-coated with a minimal amount of Ease Release 200 (Isle of man Formulated Products, Easton, PA) mold lubricant to facilitate

Scaffold morphology

Scaffolds fabricated with the injection molding technique possessed macro-architecture consistent with the mold design, as shown by the photographs in Fig. 2. The scaffolds' geometrical and dimensional properties were reproducible and were maintained with a fair degree of manual manipulation, such as what might be expected during neurosurgical implantation. Micro-CT analysis revealed the seven large channels that remained intact throughout the length of each scaffold, with highly porous walls

Give-and-take

The fabrication technique described was chosen for its versatility and simplicity. Virtually any polymer, degradable or inert, could feasibly be used, along with an advisable solvent if necessary. The scaffold components feel just temperatures and pressures at or below ambient in this injection molding process. Thus, bioactive molecules tin can exist incorporated without risk of denaturation or degradation due to high heat or pressure. A variety of techniques for the production of pores can

Conclusions

The data shown in the nowadays work signal that a elementary injection molding/solvent evaporation technique may be used to produce biodegradable scaffolds with multiple-channel geometry. Scaffolds fabricated via these techniques possessed a relatively loftier void fraction, which could be modulated past changing the initial polymer concentration. Void space interconnectivity was plant to increase every bit void fraction increased. Scaffolds degraded predictably in vitro, during which time sustained drug

Acknowledgements

Funding support was provided in role by the Mayo Foundation and the National Institutes of Health through grants AR45871 to Dr. Yaszemski's laboratory, EB02390 to Dr. Windebank's laboratory, and pre-doctoral fellowship NS45544 to the first author. The authors would also like to give thanks Mr. James Gruetzmacher for GPC analysis, Ms. LouAnn Gross for microscopy sample processing, Mr. Fred Schultz for help with mold design and manufacturing, Mr. Adam Ellison for assistance with CAD, and the

Cited past (230)

  • Motor and sensitive recovery afterwards injection of a physically cross-linked PNIPAAm-thou-PEG hydrogel in rat hemisectioned spinal string

    2020, Materials Scientific discipline and Engineering C

    These biomaterials can be natural (i.e., biopolymers of agarose, alginate, chitosan, collagen, fibrin …), constructed [poly(2-hydroxyethyl methacrylate) (pHEMA), poly(lactic acrid) (PLA), polyethylene glycol (PEG), poly(d,50-lactic acid-co-glycolic acid) (PLGA) …. ] or hybrid (hyaluronic acrid-PEG, chitosan-methacrylamide, …), cytocompatible, non-immunogenic, chemically stable, degradable and resorbable [1–ix]. They have been used for delivering drug and cells, limiting the inflammatory reaction and the glial scar development, filling the cystic cavities and/or providing structural support for regenerating neurons later a SCI [10,eleven].

View all citing articles on Scopus
View full text

Copyright © 2005 Elsevier Ltd. All rights reserved.